Proposed issue of securities - CYP
Released
Released
Announcement PDF
Appendix 3B - Proposed issue of securities
Appendix 3B - Proposed issue of securities 1 / 5
Announcement Summary
Entity name
CYNATA THERAPEUTICS LIMITED
Announcement Type
New announcement
Date of this announcement
13/11/2026
The Proposed issue is:
Total number of +securities proposed to be issued for a placement or other type of issue
ASX +security code +Security description
Maximum Number of
+securities to be issued
CYPAY OPTION EXPIRING 03-MAY-2029 8,200,000
Proposed +issue date
21/1/2027
Refer to next page for full details of the announcement
A placement or other type of issue
Appendix 3B - Proposed issue of securities
Appendix 3B - Proposed issue of securities 2 / 5
Part 1 - Entity and announcement details
1.1 Name of +Entity
CYNATA THERAPEUTICS LIMITED
We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees
to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in
Appendix 3B of the ASX Listing Rules.
If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also
apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set
out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under
the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX
an Appendix 2A online form notifying ASX of their issue and applying for their quotation).
1.2 Registered Number Type
ACN
Registration Number
104037372
1.3 ASX issuer code
CYP
1.4 The announcement is
1.5 Date of this announcement
13/11/2026
1.6 The Proposed issue is:
A placement or other type of issue
New announcement
Appendix 3B - Proposed issue of securities
Appendix 3B - Proposed issue of securities 3 / 5
Part 7 - Details of proposed placement or other issue
Part 7A - Conditions
7A.1 Do any external approvals need to be obtained or other conditions satisfied before the placement or other
type of issue can proceed on an unconditional basis?
7A.1a Conditions
Approval/Condition
+Security holder approval
Date for determination
21/1/2027
Is the date estimated or
actual?
** Approval
received/condition met?
Comments
Shareholder approval to be obtained for the proposed issue of the Placement Shares and Placement Fee Options.
Part 7B - Issue details
Is the proposed security a 'New
class' (+securities in a class that is
not yet quoted or recorded by ASX)
or an 'Existing class' (additional
securities in a class that is already
quoted or recorded by ASX)?
Will the proposed issue of this
+security include an offer of
attaching +securities?
Details of +securities proposed to be issued
ASX +security code and description
CYPAY : OPTION EXPIRING 03-MAY-2029
Number of +securities proposed to be issued
8,200,000
Offer price details
Are the +securities proposed to be issued being issued for a cash
consideration?
Please describe the consideration being provided for the +securities
Placement Fee Options to be issued pursuant to ASX announcements 4/11/2026 and 13/11/2026.
Please provide an estimate of the AUD equivalent of the consideration being provided for the +securities
Will these +securities rank equally in all respects from their issue date with
the existing issued +securities in that class?
No
No
Existing class
Estimated
Yes
Appendix 3B - Proposed issue of securities
Appendix 3B - Proposed issue of securities 4 / 5
the existing issued +securities in that class?
Part 7C - Timetable
7C.1 Proposed +issue date
21/1/2027
Part 7D - Listing Rule requirements
7D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1?
7D.1a Date of meeting or proposed meeting to approve the issue under listing rule 7.1
21/1/2027
7D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue?
7D.3 Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules?
7D.4 Will any of the +securities to be issued be subject to +voluntary escrow?
Part 7E - Fees and expenses
7E.1 Will there be a lead manager or broker to the proposed issue?
7E.1a Who is the lead manager/broker?
Caravel Securities Pty Ltd
7E.1b What fee, commission or other consideration is payable to them for acting as lead manager/broker?
6% of the funds raised by the Placement Shares and 8,200,000 $0.02 3 May 2029 Placement Fee Options
7E.2 Is the proposed issue to be underwritten?
7E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed issue
Part 7F - Further Information
7F.01 The purpose(s) for which the entity is issuing the securities
Placement Fee Options to be issued pursuant to the terms of the broker mandate.
7F.1 Will the entity be changing its dividend/distribution policy if the proposed issue proceeds?
7F.2 Any other information the entity wishes to provide about the proposed issue
No
No
Yes
No
No
No
Yes
Yes
Appendix 3B - Proposed issue of securities
Appendix 3B - Proposed issue of securities 5 / 5
7F.2 Any other information the entity wishes to provide about the proposed issue
Share your feedback
Discover